Emerging tier · Anti-Aging & Longevity

Methylene Blue for Anti-Aging & Longevity

Emerging ResearchFDA Approved

A synthetic dye with FDA approval for methemoglobinemia, now explored for cognitive and mitochondrial support.

Medical Disclaimer

This page is for educational purposes only. It is not a treatment protocol or prescription. All compounds require medical supervision. Consult a qualified healthcare provider before use.

Why Methylene Blue for Anti-Aging & Longevity

Role in Protocol

Mitochondrial electron carrier

Evidence Note

Acts as an alternative electron carrier in the mitochondrial electron transport chain. Preclinical data show improved mitochondrial function and neuroprotection. Human longevity data are preliminary.

Dosing Context

Cognitive Enhancement (Low-Dose)

Dose

0.5–25 mg

Frequency

daily

Alzheimer's Dose-Finding Trial

Dose

69–228 mg

Frequency

daily

Full dosing guide →

Often Used Alongside

GH Secretagogues (Sermorelin, CJC-1295/Ipamorelin)

Growth hormone axis support

Key Safety Notes

G6PD deficiency

Risk of severe haemolytic anaemia. Screen all patients before use.

Severe renal insufficiency

Methylene blue is primarily renally excreted.

Known hypersensitivity to methylene blue or phenothiazine compounds

Cross-reactivity with phenothiazine class.

Full safety profile →

Full Methylene Blue Profile →

Full Anti-Aging & Longevity Protocol →